HealthEquity (HQY)
(Delayed Data from NSDQ)
$79.20 USD
-0.67 (-0.84%)
Updated Apr 24, 2024 04:00 PM ET
After-Market: $79.24 +0.04 (0.05%) 7:58 PM ET
3-Hold of 5 3
C Value B Growth B Momentum B VGM
Price, Consensus and EPS Surprise
HQY 79.20 -0.67(-0.84%)
Will HQY be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for HQY based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for HQY
Here's Why HealthEquity (HQY) is a Strong Growth Stock
Here's Why HealthEquity (HQY) is a Strong Growth Stock
HQY: What are Zacks experts saying now?
Zacks Private Portfolio Services
Reasons Why You Should Retain HealthEquity (HQY) Stock for Now
Why HealthEquity (HQY) is a Top Growth Stock for the Long-Term
Why HealthEquity (HQY) is a Top Growth Stock for the Long-Term
Other News for HQY
IWO: Unconvincing Small Cap Growth ETF
J.P. Morgan’s Analyst Focus List - 5 adds and 1 removal
Analysts Offer Insights on Healthcare Companies: Edgewise Therapeutics (EWTX), Healthequity (HQY) and Nuvation Bio (NUVB)
HealthEquity Expands Portfolio with Conduent Acquisition
HealthEquity (HQY): Assessing Its Market Valuation